NASDAQ:AVR

Anteris Technologies Global Q3 2026 Earnings Results & Report

Anteris Technologies Global logo
$5.06 -0.16 (-2.98%)
As of 02:47 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Anteris Technologies Global beat analyst earnings expectations but missed on revenue in its Q3 2026 results, released November 10, 2026. The company reported EPS of -$0.28 versus the -$0.3114 consensus estimate, while revenue of $519 thousand fell short of the $2.75 million estimate by $2.23 million.

Earnings Announcement Details

Quarter
Q3 2026
Time
After Market Closes
Conference Call Date
Conference Call
6:00 PM ET

Anteris Technologies Global EPS Results

Actual EPS
-$0.28
Consensus EPS
-$0.3114
Beat/Miss
Beat by +$0.0314
One Year Ago EPS
N/A
EPS Beat Rate
1 of last 5 quarters

Anteris Technologies Global Revenue Results

Actual Revenue
$519 thousand
Expected Revenue
$2.75 million
Beat/Miss
Missed by -$2.23 million
YoY Revenue Growth
N/A

Anteris Technologies Global Q3 2026 Earnings FAQ

Anteris Technologies Global (NASDAQ:AVR) reported earnings of -$0.28 per share for Q3 2026, beating the consensus estimate of -$0.3114. The report was announced on Tuesday, November 10, 2026.

Anteris Technologies Global reported revenue of $519 thousand for Q3 2026, against a consensus estimate of $2.75 million.

Anteris Technologies Global Earnings Headlines

My $247 scanner for $7
Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment that covers a full year, with no subscription and no re-bills. Every night after the close, the scanner screens nearly a thousand of America's biggest stocks. It returns a short list of qualifying setups with the exact buy price next to each one. There's nothing to install. If you decide it's not for you, you get the $7 back and keep the scanner for the year.tc pixel
Anteris Technologies Q3 Loss Narrows, Net Sales Up
See More Anteris Technologies Global Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Anteris Technologies Global? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Anteris Technologies Global and other key companies, straight to your email.

About Anteris Technologies Global

Anteris Technologies Global (NASDAQ:AVR) is a medical technology company focused on developing treatments for structural heart disease, particularly aortic valve conditions. Its work centers on transcatheter heart valve technology, which is designed to replace a damaged valve through a minimally invasive procedure.

The company’s lead product is the DurAVR transcatheter heart valve. It is made using Anteris’ ADAPT tissue technology, which processes bovine pericardial tissue for use in medical devices. The valve is designed to resemble the structure and function of a healthy aortic valve.

Anteris has roots in Australia and serves the global medical device market. Its activities include developing and evaluating its heart valve technology for potential use by clinicians treating patients with aortic valve disease.

View Anteris Technologies Global Profile